Engineering endosomolytic nanocarriers of diverse morphologies using confined impingement jet mixing
- Vanderbilt University, Nashville, TN (United States)
- The University of Rhode Island, Kingston, RI (United States)
- Northwestern University, Evanston, IL (United States)
- Northwestern University, Evanston, IL (United States); Northwestern University, Chicago, IL (United States)
- Vanderbilt University, Nashville, TN (United States); Vanderbilt University Medical Center, Nashville, TN (United States)
The clinical translation of many biomolecular therapeutics has been hindered by undesirable pharmacokinetic (PK) properties, inadequate membrane permeability, poor endosomal escape and cytosolic delivery, and/or susceptibility to degradation. Overcoming these challenges merits the development of nanoscale drug carriers (nanocarriers) to improve the delivery of therapeutic cargo. Herein, we implement a flash nanoprecipitation (FNP) approach to produce nanocarriers of diverse vesicular morphologies by using various molecular weight PEG-bl-DEAEMA-co-BMA (PEG-DB) polymers. We demonstrated that FNP can produce uniform (PDI < 0.1) particles after 5 impingements, and that by varying the copolymer hydrophilic mass fraction, FNP enables access to a diverse variety of nanoarchitectures including micelles, unilamellar vesicles (polymersomes), and multi-compartment vesicles (MCVs). We synthesized a library of 2 kDa PEG block copolymers, with DEAEMA-co-BMA second block molecular weights of 3, 6, 12, 15, 20, and 30 kDa. All formulations were both pH responsive, endosomolytic, and capable of loading and cytosolically delivering small negatively charged molecules – albeit to different degrees. Using a B16.F10 melanoma model, we showcased the therapeutic potential of a lead FNP formulated PEG-DB nanocarrier, encapsulating the cyclic dinucleotide (CDN) cGAMP to activate the stimulator of interferon genes (STING) pathway in a therapeutically relevant context. Collectively, these data demonstrate that an FNP process can be used to formulate pH-responsive nanocarriers of diverse morphologies using a PEG-DB polymer system. As FNP is an industrially scalable process, these data address the critical translational challenge of producing PEG-DB nanoparticles at scale. Furthermore, the diverse morphologies produced may specialize in the delivery of distinct biomolecular cargos for other therapeutic applications, implicating the therapeutic potential of this platform in an array of disease applications.
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- European Union's Horizon 2020 Research and Innovation Programme; National Institutes of Health (NIH); National Science Foundation (NSF); Stand Up To Cancer (SU2C); Susan G. Komen Foundation; USDOE Office of Science (SC), Basic Energy Sciences (BES). Scientific User Facilities (SUF); Vanderbilt Institute of Chemical Biology and the Vanderbilt Ingram Cancer Center
- Grant/Contract Number:
- AC02-06CH11357
- OSTI ID:
- 2470214
- Journal Information:
- Nanoscale, Journal Name: Nanoscale Journal Issue: 39 Vol. 15; ISSN 2040-3364
- Publisher:
- Royal Society of ChemistryCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Synthesis and Purification of Homogeneous Lipid-Based Peptide Nanocarriers by Overcoming Phospholipid Ester Hydrolysis
Nanocarrier-loaded block copolymer dual domain organogels
Intracellular Biomacromolecule Delivery by Stimuli-Responsive Protein Vesicles Loaded by Hydrophobic Ion Pairing
Journal Article
·
Wed Oct 24 20:00:00 EDT 2018
· ACS Omega
·
OSTI ID:1735938
Nanocarrier-loaded block copolymer dual domain organogels
Journal Article
·
Sat Nov 20 19:00:00 EST 2021
· Polymer
·
OSTI ID:1788377
Intracellular Biomacromolecule Delivery by Stimuli-Responsive Protein Vesicles Loaded by Hydrophobic Ion Pairing
Journal Article
·
Mon Jan 13 19:00:00 EST 2025
· ACS Omega
·
OSTI ID:2538134